Cargando…

MicroRNA-134 plasma levels before and after treatment with valproic acid for epilepsy patients

BACKGROUND: Temporal lobe epilepsy is the second most common neurological disorders characterized by recurrent spontaneous seizures. MicroRNAs play a vital role in regulating synaptic plasticity, brain development and post-transcriptional expression of proteins. In both animal models of epilepsy and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xiaofeng, Luo, Yifeng, Liu, Shuangxi, Tan, Liming, Wang, Sanhu, Man, Rongyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641166/ https://www.ncbi.nlm.nih.gov/pubmed/29069823 http://dx.doi.org/10.18632/oncotarget.20292

Ejemplares similares

Targeting microRNA-134 for seizure control and disease modification in epilepsy
por: Morris, Gareth, et al.
Publicado: (2019)

MicroRNA hsa-miR-134 is a circulating biomarker for mesial temporal lobe epilepsy
por: Avansini, Simoni H., et al.
Publicado: (2017)

Valproic acid as a microRNA modulator to promote neurite outgrowth
por: Oikawa, Hirotaka, et al.
Publicado: (2016)

MicroRNA-134 as a potential plasma biomarker for the diagnosis of acute pulmonary embolism
por: Xiao, Junjie, et al.
Publicado: (2011)

MicroRNA-221-3p Suppresses the Microglia Activation and Seizures by Inhibiting of HIF-1α in Valproic Acid-Resistant Epilepsy
por: Fu, Meng, et al.
Publicado: (2021)

Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences
por: Romoli, Michele, et al.
Publicado: (2019)

Valproic acid for children below 2 years of age with epilepsy
por: Muthaffar, Osama Y., et al.
Publicado: (2021)

MicroRNA-134 regulates poliovirus replication by IRES targeting
por: Bakre, Abhijeet A., et al.
Publicado: (2017)

Overexpression of Homer1b/c induces valproic acid resistance in epilepsy
por: Wang, Yan, et al.
Publicado: (2022)

Circulating microRNA 134 sheds light on the diagnosis of major depressive disorder
por: Zhang, Han-ping, et al.
Publicado: (2020)

Risk Factors of Hyperammonemia in Patients With Epilepsy Under Valproic Acid Therapy
por: Tseng, Yu-Lung, et al.
Publicado: (2014)

RNA-seq analysis of blood of valproic acid-responsive and non-responsive pediatric patients with epilepsy
por: Wang, Yan, et al.
Publicado: (2019)

Evaluation of Cardiac Repolarization Indices in Epilepsy Patients Treated with Carbamazepine and Valproic Acid
por: Asoğlu, Ramazan, et al.
Publicado: (2020)

Replacement of Valproic Acid with New Anti-Seizure Medications in Idiopathic Generalized Epilepsy
por: Fujimoto, Ayataka, et al.
Publicado: (2022)

Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects
por: Jimenez-Mateos, Eva M., et al.
Publicado: (2012)

Circulating microRNAs are promising novel biomarkers for drug-resistant epilepsy
por: Wang, Jun, et al.
Publicado: (2015)

Liquid chromatography–tandem mass spectrometry method for simultaneous determination of valproic acid and its ene-metabolites in epilepsy patient plasma()
por: Lu, Huan, et al.
Publicado: (2016)

Genetic and Non-genetic Factors Contributing to the Significant Variation in the Plasma Trough Concentration-to-Dose Ratio of Valproic Acid in Children With Epilepsy
por: Xu, Ze-Yue, et al.
Publicado: (2021)

Valproic-induced Hyperammonemic Encephalopathy in a Known Case of Epilepsy
por: Imam, Syed F, et al.
Publicado: (2017)

“TORNADO” – Theranostic One-Step RNA Detector; microfluidic disc for the direct detection of microRNA-134 in plasma and cerebrospinal fluid
por: McArdle, Hazel, et al.
Publicado: (2017)

Circulating MicroRNAs From Plasma Small Extracellular Vesicles as Potential Diagnostic Biomarkers in Pediatric Epilepsy and Drug-Resistant Epilepsy
por: Wang, Yilong, et al.
Publicado: (2022)

Antagomir-mediated suppression of microRNA-134 reduces kainic acid-induced seizures in immature mice
por: Campbell, Aoife, et al.
Publicado: (2021)

MicroRNA regulation and dysregulation in epilepsy
por: Dogini, Danyella B., et al.
Publicado: (2013)

Evaluation of MicroRNAs in Pediatric Epilepsy
por: Çarman, Kürşat Bora, et al.
Publicado: (2023)

Assessment of atherosclerotic risk among patients with epilepsy on valproic acid, lamotrigine, and carbamazepine treatment
por: Zuberi, Nudrat A., et al.
Publicado: (2017)

Genome-wide circulating microRNA expression profiling indicates biomarkers for epilepsy
por: Wang, Jun, et al.
Publicado: (2015)

The association of adjusted plasma valproic acid concentration with CYP2C9 gene polymorphism in patients with epilepsy: a systematic review and meta-analysis
por: Fang, Huihui, et al.
Publicado: (2021)

Shifting Valproic Acid to Levetiracetam in Women of Childbearing Age With Epilepsy: A Retrospective Investigation and Review of the Literature
por: Kuo, Cheng-Yen, et al.
Publicado: (2020)

Clinical Validation and Implications of Dried Blood Spot Sampling of Carbamazepine, Valproic Acid and Phenytoin in Patients with Epilepsy
por: Kong, Sing Teang, et al.
Publicado: (2014)

Association of LEPR and ANKK1 Gene Polymorphisms with Weight Gain in Epilepsy Patients Receiving Valproic Acid
por: Li, Hongliang, et al.
Publicado: (2015)

Determination of the Optimal Concentration of Valproic Acid in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis
por: Nakashima, Hiroo, et al.
Publicado: (2015)

First‐line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid
por: van der Meer, Pim B., et al.
Publicado: (2021)

Association of ABCB1 Polymorphisms with Efficacy and Adverse Drug Reactions of Valproic Acid in Children with Epilepsy
por: Zhu, Jiahao, et al.
Publicado: (2023)

Ruyiping formula inhibits metastasis via the microRNA-134-SLUG axis in breast cancer
por: Jiang, Ziwei, et al.
Publicado: (2021)

Data on social transmission of food preference in a model of autism induced by valproic acid and translational analysis of circulating microRNA
por: Hirsch, Mauro Mozael, et al.
Publicado: (2018)

The Challenge of microRNA as a Biomarker of Epilepsy
por: Ma, Yihong
Publicado: (2018)

MicroRNAs as Potential Biomarkers for Childhood Epilepsy
por: Elnady, Hala G., et al.
Publicado: (2019)

MicroRNA-134 Promotes the Development of Atherosclerosis Via the ANGPTL4/LPL Pathway in Apolipoprotein E Knockout Mice
por: Ye, Qiong, et al.
Publicado: (2018)

Effects of valproic acid on skeletal metabolism in children with epilepsy: a systematic evaluation and meta-analysis based on 14 studies
por: Min, Li, et al.
Publicado: (2020)

Sodium 5-amino-1,3,4-thiadiazole-2-thiolate dihydrate
por: Wu, Jiayi, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_jqckvu5l3f49u9sbdnb1hq8ju5